Attended by executive thought leaders and innovative companies, the 2018 DxConferences feature a lineup of experts from payers, leading diagnostics companies and firms working to advance the industry. 


Payer Panels

In parallel to the main conference, exclusive panels with payer medical directors, are open on a first-come basis to companies seeking an unmatched opportunity to learn about reimbursement direct from the source. 


DxCONFERENCE IS THE PREMIER VENUE FOR THOUGHT LEADERS AND EXECUTIVES in personalized medicine seeking to successfully launch and grow new diagnostics. Participants bring perspectives from leading diagnostic companies, pharmaceutical manufacturers, payers, and other stakeholders. 

The Fall 2018 edition will explore the rise of companion diagnostics and how pharma and diagnostics companies can collaborate to increase opportunities in a growing market.

Attendees will build their networks with decision makers in interactive professional and social settings, and come away better equipped to address opportunities and challenges in the diagnostics marketplace.    



Who Should Attend?

DxConference is ideal for executives from diagnostics and pharmaceutical manufacturers, as well as Medical Directors, Reimbursement Directors, Case Managers, Sales and Marketing Directors, and leaders from other healthcare organizations with a strategic investment in diagnostics.





The fall event will be held September 13-14, 2018 in San Francisco, California at the Intercontinental Mark Hopkins


The 2019 spring event will be held in March in Boston, Massachusetts at the Seaport Hotel & World Trade CenterOne



Registration Rate: $1,595

Please contact us for Group Discounts.

A block of hotel rooms and reservations for DxConference will be available when you register online.

Keynote Speakers

The 2018 DxConference in San Fransciso features a lineup of experts from payers, leading diagnostics companies and firms. Speakers will be announced shortly. 


First Last


Bio copy


First Last


Bio copy


First Last


Bio copy

Corporate Partners


Our mission is to improve the quality of healthcare by encouraging research, development, and commercialization of innovative diagnostic technologies that personalize patient care, improve patient outcomes, and substantially reduce healthcare costs.

Healthcare is one of the most intricate and constantly changing areas of the law. For nearly seven decades, Foley Hoag has kept its healthcare clients ahead of the shifts and out of the gray areas with an approach built on its deep understanding of healthcare law and a strong tradition of developing innovative legal solutions to your needs.